Literature DB >> 18684811

Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice.

Roza Izmailyan1, Wen Chang.   

Abstract

The vaccinia virus WR53.5L/F14.5L gene encodes a small conserved protein that was not detected previously. However, additional proteomic analyses of different vaccinia virus isolates and strains revealed that the WR53.5 protein was incorporated into intracellular mature virus (IMV). The WR53.5 protein contains a putative N-terminal transmembrane region and a short C-terminal region. Protease digestion removed the C terminus of WR53.5 protein from IMV particles, suggesting a similar topology to that of the IMV type II transmembrane protein. We generated a recombinant vaccinia virus, vi53.5L, that expressed WR53.5 protein under isopropyl-beta-d-thiogalactopyranoside (IPTG) regulation and found that the vaccinia virus life cycle proceeded normally with or without IPTG, suggesting that WR53.5 protein is not essential for vaccinia virus growth in cell cultures. Interestingly, the C-terminal region of WR53.5 protein was exposed on the cell surface of infected cells and mediated calcium-independent cell adhesion. Finally, viruses with inactivated WR53.5L gene expression exhibited reduced virulence in mice when animals were inoculated intranasally, demonstrating that WR53.5 protein was required for virus virulence in vivo. In summary, we identified a new vaccinia IMV envelope protein, WR53.5, that mediates cell adhesion and is important for virus virulence in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684811      PMCID: PMC2566269          DOI: 10.1128/JVI.00816-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.

Authors:  W W Yeh; B Moss; E J Wolffe
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.

Authors:  C L Lin; C S Chung; H G Heine; W Chang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis.

Authors:  G S Goldberg; Z Jin; H Ichikawa; A Naito; M Ohki; W S El-Deiry; H Tsuda
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3.

Authors:  Todd D Prickett; David L Brautigan
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

7.  Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure.

Authors:  K Pedersen; E J Snijder; S Schleich; N Roos; G Griffiths; J K Locker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 8.  Cell adhesion molecules in chemically-induced renal injury.

Authors:  Walter C Prozialeck; Joshua R Edwards
Journal:  Pharmacol Ther       Date:  2007-01-23       Impact factor: 12.310

9.  Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions.

Authors:  Nathan P Manes; Ryan D Estep; Heather M Mottaz; Ronald J Moore; Therese R W Clauss; Matthew E Monroe; Xiuxia Du; Joshua N Adkins; Scott W Wong; Richard D Smith
Journal:  J Proteome Res       Date:  2008-01-19       Impact factor: 4.466

10.  Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

Authors:  Qian Zhang; Yong A Yu; Ena Wang; Nanhai Chen; Robert L Danner; Peter J Munson; Francesco M Marincola; Aladar A Szalay
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

View more
  9 in total

1.  Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.

Authors:  Zhilong Yang; Shuai Cao; Craig A Martens; Stephen F Porcella; Zhi Xie; Ming Ma; Ben Shen; Bernard Moss
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 2.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

3.  Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling.

Authors:  Roza Izmailyan; Jye-Chian Hsao; Che-Sheng Chung; Chein-Hung Chen; Paul Wei-Che Hsu; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

4.  Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates.

Authors:  Jennifer Reinboth; Maria L Ascierto; Nanhai G Chen; Qian Zhang; Yong A Yu; Richard J Aguilar; Rafael Carretero; Andrea Worschech; Yingdong Zhao; Ena Wang; Francesco M Marincola; Aladar A Szalay
Journal:  Hum Gene Ther Methods       Date:  2012-11-06       Impact factor: 2.396

5.  Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.

Authors:  Nanhai G Chen; Yong A Yu; Qian Zhang; Aladar A Szalay
Journal:  J Transl Med       Date:  2011-09-27       Impact factor: 5.531

6.  A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.

Authors:  Mary E Carter; Andreas D Hartkopf; Anna Wagner; Léa L Volmer; Sara Y Brucker; Susanne Berchtold; Ulrich M Lauer; André Koch
Journal:  Front Mol Biosci       Date:  2022-02-11

7.  New composition of tungsten has a broad range of antiviral activity.

Authors:  Hranush Avagyan; Anaida Mirzoyan; Ferdinand Mirzoyan; Roza Izmailyan; Sona Hakobyan; Henry Voskanyan; Zara Semerjyan; Aida Avetisyan; Hranush Arzumanyan; Elena Karalova; Liana Abroyan; Lina Hakobyan; Nane Bayramyan; Nazeli Gevorgyan; Alexander Karalyan; Zaven Karalyan
Journal:  Antivir Chem Chemother       Date:  2022 Jan-Dec

8.  The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.

Authors:  Qian Zhang; Chunguang Liang; Yong A Yu; Nanhai Chen; Thomas Dandekar; Aladar A Szalay
Journal:  Mol Genet Genomics       Date:  2009-08-22       Impact factor: 3.291

Review 9.  Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.

Authors:  Chad R Irwin; Mary M Hitt; David H Evans
Journal:  Front Oncol       Date:  2017-09-26       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.